Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s): QNTM

Healthcare

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.

CSE:QNTM - Post by User

Quantum BioPharma Ltd > New little animation on the lucid psych is up on twitter

<< Previous

Bullboard Posts

Next >>

Comment by DavidRosenbergon Feb 14, 2022 3:05pm

63 Views

Post# 34427308

RE:RE:New little animation on the lucid psych is up on twitter

Mil_Man54 wrote: More paid PR BS on the investor's dime....how about AD showing us actual timelines for testing and trials....how about they show us a GD solid and viable strategy with financial burn rates and projections....you know...all the stuff DD is made of.

I agree somewhat with what your saying but they already uploaded a timeline to their website

FSD Pharma has a pipeline of the following 3 drug candidates:

	Idea/Target	Phase 1	Phase 2
LUCID-MS	Multiple sclerosis	Anticipated 4th Quarter 2022
LUCID-PSYCH	Major Depression Disorder	Anticipated 4th Quarter 2022
FSD-PEA	Inflamatory disorders		Anticipated 2nd Quarter 2022